254 related articles for article (PubMed ID: 15180926)
1. Development of biomarkers in multiple sclerosis.
Bielekova B; Martin R
Brain; 2004 Jul; 127(Pt 7):1463-78. PubMed ID: 15180926
[TBL] [Abstract][Full Text] [Related]
2. Immunological markers in multiple sclerosis: tackling the missing elements.
Rinaldi L; Gallo P
Neurol Sci; 2005 Dec; 26 Suppl 4():S215-7. PubMed ID: 16388362
[TBL] [Abstract][Full Text] [Related]
3. [Cryostimulation as an antioxidative factor in sclerosis multiplex].
Miller E
Pol Merkur Lekarski; 2011 Sep; 31(183):186-9. PubMed ID: 21991852
[TBL] [Abstract][Full Text] [Related]
4. The future of multiple sclerosis treatment.
Cohen JA
J Neurol Sci; 2009 Feb; 277 Suppl 1():S55-61. PubMed ID: 19200869
[TBL] [Abstract][Full Text] [Related]
5. Treatment of children and adolescents with multiple sclerosis.
Banwell B
Expert Rev Neurother; 2005 May; 5(3):391-401. PubMed ID: 15938672
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
Minagar A; Toledo EG; Alexander JS; Kelley RE
J Neuroimaging; 2004 Jul; 14(3 Suppl):5S-10S. PubMed ID: 15228754
[TBL] [Abstract][Full Text] [Related]
7. A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development.
Severino ME; Dubose RF; Patterson SD
IDrugs; 2006 Dec; 9(12):849-53. PubMed ID: 17139572
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis: disease biomarkers as indicated by pathophysiology.
Berger T; Reindl M
J Neurol Sci; 2007 Aug; 259(1-2):21-6. PubMed ID: 17367811
[TBL] [Abstract][Full Text] [Related]
9. An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
Lolli F; Mulinacci B; Carotenuto A; Bonetti B; Sabatino G; Mazzanti B; D'Ursi AM; Novellino E; Pazzagli M; Lovato L; Alcaro MC; Peroni E; Pozo-Carrero MC; Nuti F; Battistini L; Borsellino G; Chelli M; Rovero P; Papini AM
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10273-8. PubMed ID: 16014416
[TBL] [Abstract][Full Text] [Related]
10. Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.
Bergamaschi R
Expert Rev Neurother; 2006 Mar; 6(3):357-64. PubMed ID: 16533140
[TBL] [Abstract][Full Text] [Related]
11. Informed shared decision making in multiple sclerosis--inevitable or impossible?
Heesen C; Kasper J; Köpke S; Richter T; Segal J; Mühlhauser I
J Neurol Sci; 2007 Aug; 259(1-2):109-17. PubMed ID: 17400253
[TBL] [Abstract][Full Text] [Related]
12. [Immunomodulatory therapy in multiple sclerosis].
Csépány T; Bereczki D
Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
[TBL] [Abstract][Full Text] [Related]
13. Current evidence and therapeutic strategies for multiple sclerosis.
Wingerchuk DM
Semin Neurol; 2008 Feb; 28(1):56-68. PubMed ID: 18256987
[TBL] [Abstract][Full Text] [Related]
14. Toward the development of rational therapies in multiple sclerosis: what is on the horizon?
Hemmer B; Hartung HP
Ann Neurol; 2007 Oct; 62(4):314-26. PubMed ID: 17969020
[TBL] [Abstract][Full Text] [Related]
15. [Biomarkers in multiple sclerosis].
Fernández Ó; Arroyo-González R; Rodríguez-Antigüedad A; García-Merino JA; Comabella M; Villar LM; Izquierdo G; Tintoré M; Oreja-Guevara C; Álvarez-Cermeño JC; Meca-Lallana JE; Prieto JM; Ramió-Torrentà L; Martínez-Yélamos S; Montalban X
Rev Neurol; 2013 Apr; 56(7):375-90. PubMed ID: 23520007
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy in multiple sclerosis.
Fernández O
J Neurol Sci; 2007 Aug; 259(1-2):95-103. PubMed ID: 17507031
[TBL] [Abstract][Full Text] [Related]
17. New science-based endpoints to accelerate oncology drug development.
Kelloff GJ; Sigman CC
Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
[TBL] [Abstract][Full Text] [Related]
18. Interferon-beta1b in multiple sclerosis.
Buttmann M; Rieckmann P
Expert Rev Neurother; 2007 Mar; 7(3):227-39. PubMed ID: 17341170
[TBL] [Abstract][Full Text] [Related]
19. Antigen-specific therapies in multiple sclerosis.
Giacomini PS; Bar-Or A
Expert Opin Emerg Drugs; 2009 Sep; 14(3):551-60. PubMed ID: 19708820
[TBL] [Abstract][Full Text] [Related]
20. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller DH; Montalban X; Polman C; Rocca MA; Thompson AJ; Yousry TA; Filippi M
Neurology; 2009 May; 72(19):1693-701. PubMed ID: 19433744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
